 |
4-[(2E)-1-Oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl]-1-piperazinecarboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Retinitis pigmentosa |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-08 00:00:00 |
| Sponsor | Shire HGT, Inc.;300 Shire Way;Lexington, Massachusetts, 02421 |
Related Access Program